(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMAS CRISTALINAS DO RECEPTOR DE QUIMIOCINA C-C ANTAGONISTA TIPO 4 E USOS DAS MESMAS

Em ExigênciaInvention PatentPCT · US2020060575

Application data

Number

112022009331

Type

Invention Patent

Filing

11/13/2020

Publication

08/09/2022

PCT

US2020060575

Progress at the INPI

Technical opinion to answer
  1. Filing11/13/20
  2. Publication08/09/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 02/18/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

RAPT THERAPEUTICS, INC.

US

Inventors

D. A. (pessoa física)

US

D. W. (pessoa física)

US

D. R. (pessoa física)

US

M. Z. (pessoa física)

US

O. R. (pessoa física)

US

S. K. (pessoa física)

US

Technical data

Priority claims

US

62/935,007 · 11/13/2019

Abstract

FORMAS CRISTALINAS DO RECEPTOR DE QUIMIOCINA C-C ANTAGONISTA TIPO 4 E USOS DAS MESMAS. São fornecidas formas cristalinas de um antagonista do receptor de quimiocina C-C tipo 4 (CCR4), formas de dosagem oral das mesmas e métodos de uso e preparação das mesmas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

02/18/2025

RPI 2824

Notificação de entrada na fase nacional - PCT

#1.3

08/09/2022

RPI 2692

Alteração de dados cadastrais

#1.1

05/24/2022

RPI 2681

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.